Viz.ai Earns Back-to-Back No. 1 Ranking in AI Clinical Decision Support Survey

The AI-powered stroke detection platform has been recognized as the top solution in consecutive years.

Apr. 9, 2026 at 6:11pm by

A highly detailed, glowing 3D illustration of a brain scan with pulsing neon blue and purple lights, conceptually representing the advanced AI technology used by Viz.ai to detect signs of stroke.Viz.ai's AI-powered stroke detection platform aims to expedite critical care by rapidly analyzing brain scans and alerting specialists to potential life-threatening conditions.San Francisco Today

Viz.ai, an artificial intelligence-powered stroke detection platform, has been ranked the number one clinical decision support solution in the Black Book survey for the second consecutive year. The San Francisco-based company's AI technology is designed to rapidly analyze brain scans and alert specialists to potential strokes, helping to expedite critical care.

Why it matters

Accurate and timely stroke detection is crucial, as the faster a patient receives treatment, the better their chances of recovery. Viz.ai's AI-powered platform aims to streamline this process, potentially saving lives and reducing long-term disability for stroke victims.

The details

Viz.ai's AI algorithms are trained to detect signs of stroke in brain scans, such as blockages or bleeding. The platform then immediately notifies the appropriate stroke specialists, allowing them to review the scan and initiate treatment more quickly. This automation and early detection can be the difference between a full recovery and permanent disability or even death for stroke patients.

  • Viz.ai was first ranked the number one clinical decision support solution in the Black Book survey in 2025.
  • The company has now earned the top spot for a second consecutive year in 2026.

The players

Viz.ai

An artificial intelligence-powered stroke detection platform based in San Francisco.

Got photos? Submit your photos here. ›

What they’re saying

“We are honored to be recognized as the top clinical decision support solution for the second year in a row. This achievement is a testament to the hard work and dedication of our team in developing innovative AI technology to improve stroke care.”

— Chris Mansi, CEO, Viz.ai

What’s next

Viz.ai plans to continue expanding the capabilities of its AI platform and exploring new applications in other areas of healthcare.

The takeaway

Viz.ai's back-to-back top rankings demonstrate the growing importance of AI-powered clinical decision support tools in the medical field, particularly for time-sensitive conditions like strokes where early detection can significantly improve patient outcomes.